- JP-listed companies
- FRONTEO,Inc.
- Financials
- Operating income
FRONTEO,Inc. (2158)
Market cap
¥32B
P/E ratio
51.9x
FRONTEO provides AI-powered solutions for drug discovery, compliance, and legal investigations using its proprietary KIBIT technology to serve healthcare, corporate, and legal clients.
| Period End | Operating income (Million JPY) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 528 | -384.66% |
| Mar 31, 2024 | -185 | -86.39% |
| Mar 31, 2023 | -1,362 | -179.11% |
| Mar 31, 2022 | 1,722 | +239.44% |
| Mar 31, 2021 | 507 | -160.07% |
| Mar 31, 2020 | -844 | -445.50% |
| Mar 31, 2019 | 244 | +37.53% |
| Mar 31, 2018 | 178 | -114.73% |
| Mar 31, 2017 | -1,207 | -1845.67% |
| Mar 31, 2016 | 69 | -74.02% |
| Mar 31, 2015 | 266 |